Individual and joint association of α-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects

Shouqun Jiang, Gloria Mao, Xiaofeng Zhang, Xiumei Hong, Gau‐Jun Tang, Zandong Li, Xiaoqing Liu, Yi Zhang, Bo Wang, Xian XuClinical 2005 · DOI

Abstract

Our data suggest that the alpha1A-AR Arg347Cys polymorphism is associated with BP response (particularly DBP) to short-term irbesartan treatment. Our data also showed evidence of an interaction between the alpha1A-AR Arg347Cys polymorphism and the plasma level of irbesartan in relation to BP therapeutic response. The association of the Arg347Cys polymorphism with the BP therapeutic response was more pronounced in those patients with higher plasma concentrations of irbesartan.
BibTeX
@inproceedings{jiang2005individual,
  author = {Shouqun Jiang and Gloria Mao and Xiaofeng Zhang and Xiumei Hong and Gau‐Jun Tang and Zandong Li and Xiaoqing Liu and Yi Zhang and Bo Wang and Xian Xu},
  title = {{Individual and joint association of α-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects}},
  booktitle = {Clinical},
  year = {2005},
  doi = {10.1016/j.clpt.2005.06.003},
}

Loading related content...

Figure